A wide spectrum of skin toxicities has been described in patients receiving epidermal growth factor receptor (EGFR), inhibitors, including papulopustular rash, xerosis and fissures, pruritus, mucositis, paronychia, and hair changes.Trichomegaly of the eyelashes is a rare adverse effect of EGFR inhibitor therapy and is characterized by a paradoxical overgrowth of eyelashes. We present 3 cases of trichomegaly occurred during EGFR inhibitor therapy
Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases / Fabbrocini, Gabriella; Panariello, Luigia; Cacciapuoti, Sara; Bianca, D; Ayala, Fabio. - In: DERMATITIS. - ISSN 1710-3568. - 23:5(2012), pp. 237-238. [10.1097/DER.0b013e31826e45d7]
Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases
FABBROCINI, GABRIELLA;PANARIELLO, LUIGIA;CACCIAPUOTI, SARA;AYALA, FABIO
2012
Abstract
A wide spectrum of skin toxicities has been described in patients receiving epidermal growth factor receptor (EGFR), inhibitors, including papulopustular rash, xerosis and fissures, pruritus, mucositis, paronychia, and hair changes.Trichomegaly of the eyelashes is a rare adverse effect of EGFR inhibitor therapy and is characterized by a paradoxical overgrowth of eyelashes. We present 3 cases of trichomegaly occurred during EGFR inhibitor therapyFile | Dimensione | Formato | |
---|---|---|---|
Trichomegaly_of_the_Eyelashes_During_Therapy_With.11.pdf
accesso aperto
Descrizione: Trichomegaly
Tipologia:
Documento in Post-print
Licenza:
Accesso privato/ristretto
Dimensione
584.07 kB
Formato
Adobe PDF
|
584.07 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.